7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Spruce Biosciences, Inc
(NASDAQ:SPRB) 

SPRB stock logo

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from cong...

Founded: 2014
Full Time Employees: 15
CEO: Richard A. King  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Spruce Biosciences Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0944.241,888.482,832.723,776.964,721.25,665.436,609.67
Spruce Biosciences Days Receivable Outstanding ttm (DSO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0398.24796.481,194.721,592.961,991.22,389.442,787.68
Spruce Biosciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.81-1.55-1.29-1.03-0.78-0.52-0.260
Spruce Biosciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.81-1.55-1.29-1.03-0.78-0.52-0.260
Spruce Biosciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.571.131.72.272.843.43.97
Spruce Biosciences P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 06.7513.520.252733.7540.547.25
Spruce Biosciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.48-3.84-3.2-2.56-1.92-1.28-0.640
Spruce Biosciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.360.721.081.441.792.152.51
No extra charts and metrics for this ticker.